Replies to post #4398 on Aethlon Medical Inc (AEMD)

[Jeffpacman]

I agree. Currently, the only way to pay these new researchers is with stock. I'm pretty sure they make well over 100k a year, probably a lot more. I doubt Aethlon has any plans to pay for these new players, unless there is money we do not know about. If so, that seems to go against JJ's statements of this move helping shareholders? It would take at least a year or so to even get good revenue base from ELLSA, plus moving, set up, and distribution. JJ's primary goal is the IDE Hep C FDA studies, so why place lots of money elsewhere? IMO there must be another entity involved with this move.

[PhilB1]

Gentlemen,
Remember, the parts to make a car "whole", always cost more than the car; so it makes sense to break the science and technology into smaller parts some of which can be sold off and benefit the parent co. and it's investors. I believe JJ's way ahead of us on this.
PhilB